Why Is Mphasis Share Price Falling? Key Reasons & Share Price Target

Mphasis (NSE: MPHASIS) has declined 22% from its 52-week high of Rs 3,200 to trade near Rs 2,350, leaving thousands of retail investors wondering what went wrong. The stock currently sits closer to its 52-week low of Rs 1,980 than its peak, and the selling pressure shows no signs of immediate reversal. For a company with a market cap of Rs 44,000 Cr and a strong long-term track record, the decline has raised genuine questions.

The Mphasis share price is falling due to a combination of company-specific challenges, sector-wide headwinds, and broader macro concerns including the impact of US tariff announcements on Indian equity markets. In Q3 FY26, the company reported revenue of Rs 2,429 Cr and PAT of Rs 387 Cr, with margin at EBIT 17.8% — numbers that tell part of the story but not the full picture.

This article examines every key reason behind the Mphasis share price falling, provides a financial performance analysis based on verified data, assesses institutional positioning, and offers a realistic share price target outlook for 2026 and beyond.

About Mphasis

[Click Here – Get Free Investment Predictions]

Mphasis (NSE: MPHASIS) is a leading Indian publicly-listed company in the BFS space, with a market capitalisation of Rs 44,000 Cr. The company trades at a price-to-earnings ratio of approximately 28x and a price-to-book ratio of 5.6x. At its 52-week high of Rs 3,200, the stock commanded a significant premium that has since eroded as investors re-priced risk in the sector.

What makes the Mphasis share price fall particularly notable is the contrast between its operational scale and the extent of the market correction. With reported Q3 FY26 revenue of Rs 2,429 Cr and profit of Rs 387 Cr, the fundamental business has not collapsed — but market sentiment, institutional positioning, and macro factors have collectively pushed the stock to a level where the risk-reward requires careful reassessment.

Why Is Mphasis Share Price Falling? Key Reasons

[Tap to Access Best Research Pieces on Univest]

1. BFS Vertical Revenue Decline on DXC Volume Reduction

This is one of the primary drivers behind the Mphasis share price falling. BFS Vertical Revenue Decline has created sustained selling pressure, particularly from institutional investors who reassess sector allocations during periods of macro uncertainty. The combination of structural and cyclical headwinds in this area has led brokerages to revise their near-term earnings expectations downward.

Investors tracking Mphasis closely will note that this factor has emerged consistently across analyst reports over the past two quarters. While management has acknowledged the challenge, the timeline for resolution remains unclear, keeping downside risk elevated in the near term. Recovery will require either a reversal of the underlying trend or a sufficiently sharp fall in price to discount the risk fully.

2. US Tariff Uncertainty Hitting IT Discretionary Spending

This is one of the primary drivers behind the Mphasis share price falling. US Tariff Uncertainty Hitting has created sustained selling pressure, particularly from institutional investors who reassess sector allocations during periods of macro uncertainty. The combination of structural and cyclical headwinds in this area has led brokerages to revise their near-term earnings expectations downward.

Investors tracking Mphasis closely will note that this factor has emerged consistently across analyst reports over the past two quarters. While management has acknowledged the challenge, the timeline for resolution remains unclear, keeping downside risk elevated in the near term. Recovery will require either a reversal of the underlying trend or a sufficiently sharp fall in price to discount the risk fully.

3. CC Revenue Growth Below Peers Persistent for 4 Quarters

This is one of the primary drivers behind the Mphasis share price falling. CC Revenue Growth Below has created sustained selling pressure, particularly from institutional investors who reassess sector allocations during periods of macro uncertainty. The combination of structural and cyclical headwinds in this area has led brokerages to revise their near-term earnings expectations downward.

Investors tracking Mphasis closely will note that this factor has emerged consistently across analyst reports over the past two quarters. While management has acknowledged the challenge, the timeline for resolution remains unclear, keeping downside risk elevated in the near term. Recovery will require either a reversal of the underlying trend or a sufficiently sharp fall in price to discount the risk fully.

4. Direct Business Ramp-Up Slower Than Management Guidance

This is one of the primary drivers behind the Mphasis share price falling. Direct Business Ramp-Up Slower has created sustained selling pressure, particularly from institutional investors who reassess sector allocations during periods of macro uncertainty. The combination of structural and cyclical headwinds in this area has led brokerages to revise their near-term earnings expectations downward.

Investors tracking Mphasis closely will note that this factor has emerged consistently across analyst reports over the past two quarters. While management has acknowledged the challenge, the timeline for resolution remains unclear, keeping downside risk elevated in the near term. Recovery will require either a reversal of the underlying trend or a sufficiently sharp fall in price to discount the risk fully.

5. Jefferies and JPMorgan Downgrade Weighing on Sentiment

This is one of the primary drivers behind the Mphasis share price falling. Jefferies and JPMorgan Downgrade has created sustained selling pressure, particularly from institutional investors who reassess sector allocations during periods of macro uncertainty. The combination of structural and cyclical headwinds in this area has led brokerages to revise their near-term earnings expectations downward.

Investors tracking Mphasis closely will note that this factor has emerged consistently across analyst reports over the past two quarters. While management has acknowledged the challenge, the timeline for resolution remains unclear, keeping downside risk elevated in the near term. Recovery will require either a reversal of the underlying trend or a sufficiently sharp fall in price to discount the risk fully.

Mphasis Latest News That Impacted the Stock

A timeline of key events that have shaped the recent decline in Mphasis share price:

• Apr 2026: JPMorgan cuts target to Rs 2,200 citing BFS client budget caution

• Mar 2026: DXC Technology contract renewal at lower rates — volume headwind

• Feb 2026: Q3 FY26 CC revenue -0.4% QoQ — fourth consecutive weak quarter

• Jan 2026: Jefferies maintains Underperform; target Rs 1,800

• Dec 2025: CEO confirms direct channel share rising but pace below timeline

Financial Performance Analysis

Mphasis’s most recent quarterly numbers provide important context for understanding the share price decline. While the topline has held up reasonably, margin and profitability trends reveal the pressure building beneath the surface.

The table above highlights that while revenue remains healthy, margin trajectory and market re-pricing account for much of the share price pressure. If you want to track Mphasis’s financial metrics in real time, check the 

Univest Screener for live data, peer comparisons, and financial history going back 10+ years.

Technical Signals: What the Charts Are Saying

Mphasis is currently trading at Rs 2,350, significantly below both its 50-day moving average and 200-day moving average — a classic bearish configuration that technical analysts call a “death cross” formation when the shorter-term average crosses below the longer-term. The stock sits between its 52-week high of Rs 3,200 and its 52-week low of Rs 1,980, closer to the lower end of its range.

Key support levels to watch are Rs Rs 2,100–2,200 (52-week low area). A breakdown below the 52-week low would signal further capitulation. Key resistance on the upside sits near the 200-day moving average and then at the Rs Rs 2,700–3,000 analyst consensus range. For momentum buyers, waiting for a clear base formation before entering would be prudent.

Download the Univest iOS App or Univest Android App to track Mphasis’s live price and get daily research insights.

Market Sentiment & Institutional Positioning

Shareholding data for Mphasis reveals important signals: Promoter holding is 55.6%, FII holding stands at 14.2%, DII holding at 18.4%, and retail investors hold 11.8%. The trend in FII holding is particularly important — any decline in FII holding over the last two consecutive quarters typically signals reduced global institutional confidence in the stock.

When FII holding falls, it often creates a feedback loop: index rebalancing, ETF outflows, and domestic fund benchmark tracking all contribute to additional selling. Retail investors who entered at higher levels are particularly vulnerable to this dynamic, as institutional selling tends to be large in scale and aggressive in pace.

Future Outlook: Can Mphasis Recover?

Mphasis retains several genuine positives that could support a recovery once the current headwinds moderate. Its business fundamentals — revenue visibility, brand equity, balance sheet quality, and management track record — remain broadly intact. The current price correction may, over time, create an attractive entry opportunity for long-term investors.

Recovery catalysts would include a reversal of macro headwinds such as crude oil prices moderating, US tariff negotiations progressing favourably, or sector-specific demand picking up. An above-expectation Q4 FY26 results print combined with positive FY27 guidance could serve as the near-term trigger for price recovery.

A contrarian perspective worth considering: the market often prices in bad news faster than it actually materialises. If Mphasis’s underlying earnings hold up through FY26-27 better than feared, the current decline represents value rather than fundamental deterioration. However, patience is required — bottoms are rarely identified in real time.

Mphasis Share Price Target

[Subscribe to Univest Pro for Premium Stock Research and F&O Setups]

Short-Term Target (3–6 Months)

In the near term, Mphasis faces continued pressure with key support at Rs Rs 2,100–2,200 (52-week low area). A break below the 52-week low could see the stock test even lower levels. The bull case for the next 3–6 months would require a positive macro trigger — a US tariff pause, strong Q4 FY26 results, or FII return flows — to push the stock back toward Rs Rs 2,700.

12-Month Analyst Target

The analyst consensus 12-month target for Mphasis stands at Rs 2,700–3,000. This implies meaningful upside from current levels of Rs 2,350 — provided the company delivers on earnings expectations and macro conditions normalise. Investors should track quarterly earnings revisions, as any downward revision to FY27 estimates could push analyst targets lower.

Long-Term Target (2027–2028)

For long-term investors with a 2–3 year horizon, Mphasis has a potential target range of Rs 3,500–4,000 (BFS recovery + direct channel). This assumes normalisation of current headwinds, operational leverage kicking in, and sector-level demand returning to trend growth rates. As always, these are scenario-based estimates and depend heavily on macro factors beyond company control.

Explore the Univest Screener to track analyst upgrades, earnings revisions, and fundamental improvements in real time.

Conclusion

Mphasis share price is falling due to a combination of BFS Vertical Revenue Decline, US Tariff Uncertainty Hitting, CC Revenue Growth Below, and broader macro concerns. The stock has declined -22% from its 52-week high of Rs 3,200 to Rs 2,350. The short-term analyst target is Rs 2,100–2,200 (52-week low area) and the 12-month consensus target is Rs 2,700–3,000.

Whether this decline is a buying opportunity or a value trap depends on how quickly the underlying headwinds resolve. Long-term investors who understand the business fundamentals and can hold through volatility may find the current valuation more attractive than it appears.

This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.

FAQs

Q. Why is Mphasis share price falling in 2026?

Mphasis share price is falling primarily due to BFS Vertical Revenue Decline on DXC Volume Reduction and US Tariff Uncertainty Hitting IT Discretionary Spending. Combined with broader market selling triggered by US tariff uncertainty and FII outflows from Indian equities, the stock has declined -22% from its 52-week high of Rs 3,200. The near-term outlook remains cautious until macro conditions stabilise.

Q. What is Mphasis share price target 2026?

The 12-month analyst consensus target for Mphasis is Rs 2,700–3,000. Short-term technical support is at Rs 2,100–2,200 (52-week low area). Long-term estimates for 2027–28 project Rs 3,500–4,000 (BFS recovery + direct channel), assuming earnings recovery and macro normalisation. These are analyst projections — not guaranteed outcomes.

Q. Should I buy Mphasis shares now?

This depends on your risk tolerance and investment horizon. Mphasis’s current price of Rs 2,350 reflects significant pessimism already priced in. Long-term investors with a 2–3 year view may consider accumulating in tranches. However, the near-term trend remains negative and a rush to buy without a clear fundamental trigger carries risk.

Q. What is Mphasis’s latest news?

Recent developments impacting Mphasis include JPMorgan cuts target to Rs 2,200 citing BFS client budget caution and DXC Technology contract renewal at lower rates — volume headwind. These events have accelerated the selling pressure on the stock over the past quarter.

Q. What is Mphasis’s market cap and P/E ratio?

Mphasis has a market cap of Rs 44,000 Cr and trades at a P/E ratio of approximately 28x. The price-to-book ratio is 5.6x. These valuation metrics are higher than sector medians, which is why the stock is particularly vulnerable to earnings disappointments or macro headwinds.

Q. What is the promoter holding in Mphasis?

Promoter holding in Mphasis stands at 55.6%, with FII holding at 14.2% and DII holding at 18.4%. Changes in FII holding over consecutive quarters are an important signal of institutional confidence — declining FII holding often precedes continued price weakness.

Q. What triggers could cause Mphasis share price to recover?

Key recovery catalysts for Mphasis include moderation of US tariff concerns, a strong Q4 FY26 results print with positive FY27 guidance, FII return flows into the sector, and crude oil prices stabilising. Any two of these triggers materialising simultaneously could produce a meaningful price recovery from current levels.

Q. What are the biggest risks in Mphasis shares?

The biggest risks in Mphasis shares include continued macro headwinds from US tariffs, earnings estimate downgrades if Q4 FY26 results disappoint, further FII selling, and the possibility that BFS Vertical Revenue Decline on DXC Volume Reduction takes longer to resolve than markets currently expect. Investors should monitor quarterly earnings and analyst revision trends closely.

Disclaimer: Investments in securities are subject to market risk. Please read all related documents before investing. This content is for educational purposes only and does not constitute investment advice.

Recent Article

TCS Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast

Nestle India Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast

State Bank of India Share Price Target 2026: Analyst Forecasts, Bull & Bear Case

Hindustan Unilever Share Price Target 2026 — Key Factors, Financial Performance & Analyst Forecast